1. Benzo[a]pyrene exposure causes exonal switch resulting in reduced surface CD5 expression in an AHR-dependent manner.
- Author
-
Kumari S, Singh B, Kureel AK, Saini S, Prakash S, Chauhan A, Kumar P, Singh K, and Rai AK
- Subjects
- Humans, T-Lymphocytes immunology, T-Lymphocytes metabolism, Promoter Regions, Genetic genetics, Basic Helix-Loop-Helix Transcription Factors metabolism, Basic Helix-Loop-Helix Transcription Factors genetics, Protein Binding, Endogenous Retroviruses genetics, Endogenous Retroviruses metabolism, Binding Sites, Jurkat Cells, CD5 Antigens metabolism, CD5 Antigens genetics, Receptors, Aryl Hydrocarbon metabolism, Receptors, Aryl Hydrocarbon genetics, Benzo(a)pyrene, Exons genetics, Gene Expression Regulation
- Abstract
The function of CD5 protein in T cells is well documented, but regulation of its surface-level expression has yet to be fully understood. However, variation in its surface expression is associated with various immunopathological conditions and haematological malignancies. Briefly, expression of an alternate exon E1B of a human endogenous retroviruses (HERV) origin directly downregulates the conventional transcript variant (E1A), as its expression leads to the retention of the resultant protein at the intracellular level (cCD5). A separate promoter governs the expression of E1B and may be influenced by different transcription factors. Hence, we performed in silico transcription factor binding site (TFBS) analysis of the 3 kb upstream region from TSS of exon E1B and found five putative DREs (Dioxin Response elements) with good similarity scores. Further, we observed the upregulation in E1B expression after the exposure of BaP (a dioxin) and the reduction of E1A expression and their respective protein, i.e. sCD5 and cCD5. The binding of AHR at the predicted DRE sites was confirmed by ChIP qPCR and AHR specific inhibitor and gene silencing studies suggested the involvement of AHR in exonal switch. This study indicates that the polycyclic aromatic hydrocarbon decreases the sCD5 expression by upregulating alternative exon expression, which may adversely affect the overall T cell functions., Competing Interests: Declaration of competing interest No conflicts of interest declared., (Copyright © 2024 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF